Soleno Therapeutics Stock Forecast

Buy or Hold candidate since Apr 01, 2026 Gain 43.31%

No changes to the price of Soleno Therapeutics Inc stock on the last trading day (Tuesday, 16th Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $53.01 to a day high of $53.01. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 39.85% during the next 3 months and, with a 90% probability hold a price between $65.68 and $95.08 at the end of this 3-month period.

SLNO Signals & Forecast

The Soleno Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $53.01 and $52.97. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 15, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Soleno Therapeutics Inc stock

Soleno Therapeutics Inc finds support from accumulated volume at $52.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $50.89 (-4.00%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (SLNO) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Soleno Therapeutics Inc to open at $53.01, and during the day (based on 14 day Average True Range), to move between $52.96 and $53.06, which gives a possible trading interval of +/-$0.0927 (+/-0.17%) up or down from last closing price. If Soleno Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 0.17% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $52.60, some $0.410 (0.77%) from the current price of $53.01, our system finds the risk reward attractive.

Is Soleno Therapeutics Inc stock A Buy?

Soleno Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 17, 2026 - $53.01 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk